Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 26, 2003

View Archived Issues

GSK-3beta negatively regulates normal cardiac growth and systolic function in transgenic mice

Avant to conduct phase II trial of TP-10 in women

Accelerated development of viral inhibitor Thiovir for HIV

Beneficial effects of eplerenone in AMI patients with low LVEF

Cytochroma selects drug candidate for treatment of psoriasis

Conivaptan effects on exercise tolerance in patients with chronic heart failure

Clinical trials of MB-7133 begin in liver cancer

Tezosentan: effects on BNP and hemodynamics in acute decompensated heart failure

Carvedilol safe and effective in heart failure patients with Chagas' disease

NSAID + sumatriptan more effective than other therapies for migraine

Sustained pain relief described for subcutaneous DHE in migraine

Daptomycin equieffective to vancomycin and semisynthetic penicillin in skin infections

Phase II results reported for tigecycline in patients with skin and abdominal infections

NicOx to reacquire CINOD rights

Phase II clinical trial of ProCord for spinal cord injury

French authorities recommend against approval of Remodulin

New antiallergic/antiasthmatic agents developed at Rigel

Kissei patents new thyroid hormone receptor ligands

Novel TF/factor VIIa inhibitors under study at Roche

Elan researchers present novel gamma-secretase inhibitors

Indole-based alpha1A-adrenoceptor agonists for urinary incontinence and other uses

Ono scientists prepare and test novel PDE7 inhibitors

Name change for Myriad Proteomics

EluSys receives additional U.S. Department of Defense funds to further develop anthrax drug

Namenda recommended for approval for Alzheimer's disease

Teva and Acorda collaborate on valrocemide

Watson and UCB enter marketing and supply agreement on Oxytrol

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...